Akero Therapeutics, Inc. (AKRO)

NASDAQ: AKRO · Real-Time Price · USD

48.31

+0.28 (0.58%)

At close: Aug 13, 2025, 4:00 PM

48.54

+0.23 (0.48%)

After-hours: Aug 13, 2025, 5:03 PM EDT

Akero Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Market Capitalization	3,864	1,942	1,301	2,563	738	896	Upgrade
Market Cap Growth	162.21%	49.28%	-49.24%	247.29%	-17.63%	41.33%	Upgrade
Enterprise Value	2,814	1,191	714	2,199	524	606	Upgrade
Last Close Price	48.31	27.82	23.35	54.80	21.15	25.80	Upgrade
PB Ratio	3.76	2.59	2.43	7.85	4.36	3.46	Upgrade
P/TBV Ratio	3.77	2.59	2.43	7.85	4.36	3.46	Upgrade
Debt / Equity Ratio	0.04	0.05	0.05	0.03	0.01	0.01	Upgrade
Quick Ratio	12.29	18.69	28.75	18.42	7.49	20.47	Upgrade
Current Ratio	12.66	19.38	29.27	18.61	7.70	20.70	Upgrade
Return on Equity (ROE)	-31.14%	-39.22%	-35.22%	-45.20%	-47.11%	-40.89%	Upgrade
Return on Assets (ROA)	-20.36%	-25.37%	-23.06%	-26.07%	-26.90%	-24.35%	Upgrade
Return on Capital (ROIC)	-21.19%	-26.47%	-24.03%	-28.33%	-29.25%	-25.73%	Upgrade
Earnings Yield	-7.35%	-12.98%	-11.67%	-4.37%	-13.66%	-8.84%	Upgrade
FCF Yield	-6.56%	-11.90%	-11.18%	-3.61%	-10.80%	-7.92%	Upgrade
Buyback Yield / Dilution	-25.25%	-27.71%	-34.84%	-11.94%	-10.69%	-108.77%	Upgrade

Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q